FIELD: medicine. SUBSTANCE: method involves carrying out antitumorigenic immune response stimulation by vaccinating human patients with xenogenic tumor cells taken from animals like mice discordant with respect to human being. EFFECT: enhanced effectiveness of treatment. 2 cl
Title | Year | Author | Number |
---|---|---|---|
VACCINE FOR ANTITUMOR IMMUNITY STIMULATION | 2000 |
|
RU2192884C2 |
METHOD FOR IMMUNOTHERAPY OF CEREBRAL MALIGNANT TUMORS | 2004 |
|
RU2262941C2 |
METHOD FOR APPLYING COMBINED IMMUNOTHERAPY OF MALIGNANT BRAIN TUMORS | 2000 |
|
RU2197985C2 |
HUMAN MELANOMA CELL LINE ILG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395574C1 |
HUMAN MELANOMA CELL LINE 26G WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395571C1 |
HUMAN MELANOMA CELL LINE 31G WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395573C1 |
HUMAN MELANOMA CELL LINE PG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395570C1 |
HUMAN MELANOMA CELL LINE IG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395572C1 |
METHOD OF EVALUATION OF B-LYMPHOCYTE PROLIFERATIVE ACTIVITY IN VITRO USING BIOFLAVANOID FROM THE ROSE ROOT | 1992 |
|
RU2088932C1 |
CYTOSTATIC FACTOR OF NATURAL ORIGIN AND METHOD FOR ITS PREPARING | 2002 |
|
RU2233663C2 |
Authors
Dates
2002-11-20—Published
2000-02-07—Filed